1 July 2020 - Deborah Wilkes
Archived
Private-equity firm The Carlyle Group is taking a 20% stake in Piramal Pharma, which houses Piramal’s Consumer Products division, for around USD490 million. The investment will be used to “accelerate” Piramal Pharma’s organic and inorganic growth plans.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.